Learn More
Invitrogen™ SLAM (SLAMF1) Human ELISA Kit
Sandwich ELISA Kit
Brand: Invitrogen™ EHSLAMF1X5
Description
The Human SLAM (SLAMF1) ELISA quantitates Hu SLAM in human serum, plasma, or cell culture medium. The assay will exclusively recognize both natural and recombinant Hu SLAM. Principle of the method The Human SLAM solid-phase sandwich ELISA (enzyme-linked immunosorbent assay) is designed to measure the amount of the target bound between a matched antibody pair. A target-specific antibody has been pre-coated in the wells of the supplied microplate. Samples, standards, or controls are then added into these wells and bind to the immobilized (capture) antibody. The sandwich is formed by the addition of the second (detector) antibody, a substrate solution is added that reacts with the enzyme-antibody-target complex to produce measurable signal. The intensity of this signal is directly proportional to the concentration of target present in the original specimen. Rigorous validation Each manufactured lot of this ELISA kit is quality tested for criteria such as sensitivity, specificity, precision, and lot-to-lot consistency. See manual for more information on validation.
CD150 (SLAM, Signaling Lymphocyte Activation Molecule) belongs to the immunoglobulin gene superfamily, and is involved in T cell stimulation. SLAM is constitutively expressed on peripheral blood memory T cells, T cell clones, immature thymocytes, and a proportion of B cells, and is rapidly induced on naive T cells after activation. Activated B cells express the membrane bound form, the soluble form and the cytoplasmic isoforms of SLAM. It is suggested that signalling through homophilic SLAM-SLAM binding during B to B and B to T cell interactions enhances the expansion and differentiation of activated B cells. Reports suggest that the extracellular domain of CD150 is the receptor for the measles virus and acts as a co-activator on T cells and B cells. Moreover, CD150 is thought to interact with SH2D1A and with PTPN11 via its cytoplasmic domain. Mutations CD150 gene may be associated with X-linked lympho-proliferative disease (XLP).Specifications
Q13291 | |
60 pg/mL | |
Solid-phase sandwich ELISA | |
ELISA Kit | |
Plasma, Serum, Supernatant | |
5 x 96 assays | |
ELISA, Protein Assays, Protein Biology, Cancer Biology, Immunology, Neuroscience, Neurobiology, Protein Detection, Protein Analysis | |
6504 | |
<12% | |
Pre-coated 96 well plates, Standard, SAV-HRP, Assay Diluent Concentrate, Wash Buffer, Adhesive Plate Covers, Biotinylated Detection Antibody, Chromogen, Stop Solution | |
5 x 96 Tests | |
Cell Cycle & Proliferation | |
2°C to 8°C | |
Human | |
4 hr. 45 min. |
61.44 pg/mL to 15,000 pg/mL | |
60 pg/mL to 15,000 pg/mL | |
Biotin | |
Other Proteins | |
This ELISA pair antibody detects human SLAM. Other species not determined. | |
Human | |
Colorimetric Microplate Reader | |
CD150,CDw150,SLAM | |
<10% | |
HRP | |
RUO | |
Plasma, 50 μ;L; Serum, 50 μ;L; Supernatant, 100 μ;L | |
RP11-528G1.4, CD150, CDw150, SLAM | |
1 hr. 20 min. |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.